135 related articles for article (PubMed ID: 20841508)
1. Interleukin-7 treatment counteracts IFN-α therapy-induced lymphopenia and stimulates SIV-specific cytotoxic T lymphocyte responses in SIV-infected rhesus macaques.
Parker R; Dutrieux J; Beq S; Lemercier B; Rozlan S; Fabre-Mersseman V; Rancez M; Gommet C; Assouline B; Rancé I; Lim A; Morre M; Cheynier R
Blood; 2010 Dec; 116(25):5589-99. PubMed ID: 20841508
[TBL] [Abstract][Full Text] [Related]
2. Reduced Chronic Lymphocyte Activation following Interferon Alpha Blockade during the Acute Phase of Simian Immunodeficiency Virus Infection in Rhesus Macaques.
Carnathan D; Lawson B; Yu J; Patel K; Billingsley JM; Tharp GK; Delmas OM; Dawoud R; Wilkinson P; Nicolette C; Cameron MJ; Sekaly RP; Bosinger SE; Silvestri G; Vanderford TH
J Virol; 2018 May; 92(9):. PubMed ID: 29467313
[TBL] [Abstract][Full Text] [Related]
3. Short-Term Pegylated Interferon α2a Treatment Does Not Significantly Reduce the Viral Reservoir of Simian Immunodeficiency Virus-Infected, Antiretroviral Therapy-Treated Rhesus Macaques.
Palesch D; Bosinger SE; Mavigner M; Billingsley JM; Mattingly C; Carnathan DG; Paiardini M; Chahroudi A; Vanderford TH; Silvestri G
J Virol; 2018 Jul; 92(14):. PubMed ID: 29720521
[TBL] [Abstract][Full Text] [Related]
4. Administration of recombinant rhesus interleukin-12 during acute simian immunodeficiency virus (SIV) infection leads to decreased viral loads associated with prolonged survival in SIVmac251-infected rhesus macaques.
Ansari AA; Mayne AE; Sundstrom JB; Bostik P; Grimm B; Altman JD; Villinger F
J Virol; 2002 Feb; 76(4):1731-43. PubMed ID: 11799168
[TBL] [Abstract][Full Text] [Related]
5. IL-7 induces immunological improvement in SIV-infected rhesus macaques under antiviral therapy.
Beq S; Nugeyre MT; Ho Tsong Fang R; Gautier D; Legrand R; Schmitt N; Estaquier J; Barré-Sinoussi F; Hurtrel B; Cheynier R; Israël N
J Immunol; 2006 Jan; 176(2):914-22. PubMed ID: 16393976
[TBL] [Abstract][Full Text] [Related]
6. Th-1-type cytotoxic CD8+ T-lymphocyte responses to simian immunodeficiency virus (SIV) are a consistent feature of natural SIV infection in sooty mangabeys.
Wang Z; Metcalf B; Ribeiro RM; McClure H; Kaur A
J Virol; 2006 Mar; 80(6):2771-83. PubMed ID: 16501086
[TBL] [Abstract][Full Text] [Related]
7. Activated memory CD4(+) T helper cells repopulate the intestine early following antiretroviral therapy of simian immunodeficiency virus-infected rhesus macaques but exhibit a decreased potential to produce interleukin-2.
Mattapallil JJ; Smit-McBride Z; Dailey P; Dandekar S
J Virol; 1999 Aug; 73(8):6661-9. PubMed ID: 10400763
[TBL] [Abstract][Full Text] [Related]
8. Treatment with IL-7 prevents the decline of circulating CD4+ T cells during the acute phase of SIV infection in rhesus macaques.
Vassena L; Miao H; Cimbro R; Malnati MS; Cassina G; Proschan MA; Hirsch VM; Lafont BA; Morre M; Fauci AS; Lusso P
PLoS Pathog; 2012; 8(4):e1002636. PubMed ID: 22511868
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic vaccination with simian immunodeficiency virus (SIV)-DNA + IL-12 or IL-15 induces distinct CD8 memory subsets in SIV-infected macaques.
Halwani R; Boyer JD; Yassine-Diab B; Haddad EK; Robinson TM; Kumar S; Parkinson R; Wu L; Sidhu MK; Phillipson-Weiner R; Pavlakis GN; Felber BK; Lewis MG; Shen A; Siliciano RF; Weiner DB; Sekaly RP
J Immunol; 2008 Jun; 180(12):7969-79. PubMed ID: 18523260
[TBL] [Abstract][Full Text] [Related]
10. Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus.
Giavedoni LD; Velasquillo MC; Parodi LM; Hubbard GB; Hodara VL
J Virol; 2000 Feb; 74(4):1648-57. PubMed ID: 10644334
[TBL] [Abstract][Full Text] [Related]
11. Increased soluble IL-7 receptor concentrations associate with improved IL-7 therapy outcomes in SIV-infected ART-treated Rhesus macaques.
Steele AK; Carrasco-Medina L; Sodora DL; Crawley AM
PLoS One; 2017; 12(12):e0188427. PubMed ID: 29261677
[TBL] [Abstract][Full Text] [Related]
12. Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic simian immunodeficiency virus infection.
Nigam P; Kwa S; Velu V; Amara RR
J Immunol; 2011 Jan; 186(2):745-53. PubMed ID: 21148794
[TBL] [Abstract][Full Text] [Related]
13. Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication.
Nganou-Makamdop K; Billingsley JM; Yaffe Z; O'Connor G; Tharp GK; Ransier A; Laboune F; Matus-Nicodemos R; Lerner A; Gharu L; Robertson JM; Ford ML; Schlapschy M; Kuhn N; Lensch A; Lifson J; Nason M; Skerra A; Schreiber G; Bosinger SE; Douek DC
PLoS Pathog; 2018 Aug; 14(8):e1007246. PubMed ID: 30142226
[TBL] [Abstract][Full Text] [Related]
14. Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-human immunodeficiency virus 89.6-immunized rhesus macaques.
Abel K; La Franco-Scheuch L; Rourke T; Ma ZM; De Silva V; Fallert B; Beckett L; Reinhart TA; Miller CJ
J Virol; 2004 Jan; 78(2):841-54. PubMed ID: 14694116
[TBL] [Abstract][Full Text] [Related]
15. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge.
Dittmer U; Stahl-Hennig C; Coulibaly C; Nisslein T; Lüke W; Fuchs D; Bodemer W; Petry H; Hunsmann G
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1307-15. PubMed ID: 7782761
[TBL] [Abstract][Full Text] [Related]
16. The relationship between simian immunodeficiency virus RNA levels and the mRNA levels of alpha/beta interferons (IFN-alpha/beta) and IFN-alpha/beta-inducible Mx in lymphoid tissues of rhesus macaques during acute and chronic infection.
Abel K; Alegria-Hartman MJ; Rothaeusler K; Marthas M; Miller CJ
J Virol; 2002 Aug; 76(16):8433-45. PubMed ID: 12134046
[TBL] [Abstract][Full Text] [Related]
17. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression.
Sandler NG; Bosinger SE; Estes JD; Zhu RT; Tharp GK; Boritz E; Levin D; Wijeyesinghe S; Makamdop KN; del Prete GQ; Hill BJ; Timmer JK; Reiss E; Yarden G; Darko S; Contijoch E; Todd JP; Silvestri G; Nason M; Norgren RB; Keele BF; Rao S; Langer JA; Lifson JD; Schreiber G; Douek DC
Nature; 2014 Jul; 511(7511):601-5. PubMed ID: 25043006
[TBL] [Abstract][Full Text] [Related]
18. Administration of recombinant human interleukin 12 to chronically SIVmac-infected rhesus monkeys.
Watanabe N; Sypek JP; Mittler S; Reimann KA; Flores-Villanueva P; Voss G; Lord CI; Letvin NL
AIDS Res Hum Retroviruses; 1998 Mar; 14(5):393-9. PubMed ID: 9546798
[TBL] [Abstract][Full Text] [Related]
19. Impaired mitogen-driven proliferation and cytokine transcription of lymphocytes from macaques early after simian immunodeficiency virus (SIV) infection.
Spring M; Bodemer W; Stahl-Hennig C; Nisslein T; Hunsmann G; Dittmer U
Viral Immunol; 1997; 10(2):65-72. PubMed ID: 9210280
[TBL] [Abstract][Full Text] [Related]
20. Expression of IL-18 by SIV does not modify the outcome of the antiviral immune response.
Giavedoni LD; Velasquillo MC; Parodi LM; Hubbard GB; Hodara VL
Virology; 2002 Nov; 303(2):327-37. PubMed ID: 12490394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
